Carlo Garufi [email protected] Oncologia Medica A Istituto Regina Elena - Roma Advanced Metastatic Disease Which biological targeted agent and for whom?
A phase III study of gemcitabine ± docetaxel for metastatic soft tissue sarcoma Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno S, Samuels B, Harmon DC,
A phase III study of gemcitabine ± docetaxel for metastatic soft tissue sarcoma
A Metabolic Approach to Sarcoma Therapy
